Lundbeck sees hope in re-analysis of failed Phase III desmoteplase stroke trial
05 March 2010
Katie McQue
Please Login to read the full article.
05 March 2010
Katie McQue
katie.mcque@informa.com
A post-hoc analysis of the failed DIAS-2 Phase III study of Lundbeck's candidate for the treatment of ischaemic stroke, desmoteplase, suggests that the drug is effective in the sub-group of patients who suffered a serious stroke.
Although the trial, which reported in June 2007, failed to...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
